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rier with model drug, tramadol hydrochloride (TRM). Grafting decreased the thermal stability of
chitosan. FT-IR spectra of tablet did not reveal any molecular level (i.e. at <10 nm scale) drug–
polymer interaction. But differential scanning calorimetric studies indicated a probable drug–poly-
mer interaction at a scale >100 nm level. The observed Korsmeyer–Peppas’s power law exponents
(0.19–1.21) for the in vitro release proﬁles of TRM in SBF and other drugs such as 5-ﬂuorouracil
(FU), paracetamol (PCM) and vanlafaxine hydrochloride (VNF) with the copolymer carriers
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and the enhanced release rate for the grafts with increasing itaconic acid content in the feed were
more likely attributed to the enhanced drug–matrix interaction and polymer–SBF interactions,4295 226254; mobile: +91
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264 K. Subramanian, V. Vijayakumarrespectively. The different release proﬁles of FU, PCM, TRM and VNF with the copolymer matrix
are attributed to the different chemical structures of drugs. The above features suggest the graft
copolymer’s candidature for use as a promising oral drug delivery system.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Chitosan a biopolymer derived from chitin, the most abundant
natural biopolymer next to the cellulose, is inherently biocom-
patible (Koide, 1998), biodegradable (Ravi Kumar, 2000; Ravi
Kumar et al., 2004) and antimicrobial (Koide, 1998). Hence, it
is a widely opted candidate for investigating its medical appli-
cations such as drug delivery, wound dressing, etc., after suit-
able modiﬁcations (Zohuriaan-Mehr, 2005; Yang et al., 2008;
Bhattarai et al., 2010). But its poor physical properties such
as high brittleness and poor solubility require improvement
to widen its medical applications particularly in drug delivery,
as a carrier matrix. Many chemical and biochemical routes
have been reported to modify chitosan to improve the afore-
said properties (Mino and Kaizerman, 1958; Berlin and
Kislenko, 1992; Jenkins and Hudson, 2001; Jayakumar et al.,
2005; Hou et al., 2010; Chen et al., 2011). Among these graft-
ing of chitosan by graft copolymerization using biocompatible
and other synthetic vinyl monomers is one of the most effective
methods widely employed to incorporate desirable properties
into chitosan without sacriﬁcing its biodegradable nature.
Chitosan grafting using single vinyl monomers for drug deliv-
ery and other applications has been well studied (Singh and
Ray, 1994; Kweon and Kang, 1999; Kumbar et al., 2003;
Kumbar and Aminabhavi, 2003; El-Sherbiny et al., 2006;
Guo et al., 2008; Patel et al., 2010). But only limited studies
have been made on chitosan grafting with two monomers for
drug delivery applications. The hydrophobicity and hydrophi-
licity of the carrier contribute a lot in controlling the drug re-
lease characteristics apart from its ﬂexibility. Hence, the
present investigation is focused on the chitosan grafting using
the hydrophilic itaconic acid (IA) and the comparatively more
hydrophobic 2-hydroxyethyl methacrylate (HEMA) as como-
nomers and evaluation of the resulted chitosan grafts as a tun-
able drug carrier with tramadol hydrochloride (TRM), an
opioid analgesic as a model drug. HEMA and IA were the pre-
ferred comonomers for grafting on the ground that they do not
display any cell toxicity and hemolytic activity and possess
good resistance toward penetration of microbes (Tomic
et al., 2010). In addition to this introduction of itaconic acid
through grafting on the surface of chitosan may impart pH
sensitive swelling behavior because when the acid groups are
ionized, the coiled chains extend dramatically responding to
the electrostatic repulsions of the generated charges with in-
creased uptake of solvent in the network. Moreover, the poly-
mer–polymer and the polymer–solvent interactions show an
abrupt re-adjustment in small ranges of pH and this is trans-
lated to a chain transition between extended and compacted
coil states (Peppas et al., 2000). By introducing hydrophilic
IA and comparatively more hydrophobic HEMA as comono-
mers in the graft, the hydrophobic–hydrophilic balance in the
graft copolymer structure and their interactions between the
polymeric chains and the aqueous media can be altered to con-
trol and achieve the desirable drug release characteristics.2. Experimental
2.1. Materials
Chitosan (CTS, low density, 80–85% deacetylated), inherent
viscosity 12.2 dL/g in 0.1 M HOAc at 30 C) was purchased
from Kerala State Co-operative Federation for Fisheries
Development Ltd. and used after puriﬁcation by reprecipita-
tion. 2-Hydroxyethyl methacrylate (HEMA, Sigma–aldrich)
was puriﬁed by column chromatography on activated silica
gel just before use. Itaconic acid (IA, Himedia) was recrystal-
lized from dry methanol and dried under vacuum at 50  for
4 h and used. Potassium persulfate (KPS, Nice Chemicals)
was recrystallized with distilled water and dried. Sodium chlo-
ride, hydrochloric acid (Rankem), pepsin (Loba), anhydrous
disodium hydrogen orthophosphate and sodium dihydrogen
orthophosphate (Qualigens), potassium bromide (KBr,
Merck), methanol and acetone (SRL, India) were used as re-
ceived. Paracetamol (PCM, analgesic and antipyretic), trama-
dol hydrochloride (TRM, opioid analgesic) and venlafaxine
hydrochloride (VNF, antidepressant), were kindly gifted by
SPIC Pharma, Chennai. 5-Fluorouracil (FU, anticancer,
>99% Himedia) was used as purchased. The structures of
the drugs and monomers are given in Fig. 1. Simulated gastric
ﬂuid (SGF, pH 1.2) and phosphate buffer solution (simulated
intestinal ﬂuid, SIF, pH 7.2) were prepared as per United
States pharmacopeia.
2.2. Synthesis of chitosan-graft-poly (2-hydroxyethyl
methacrylate-co-itaconic acid) [CTS-graft-poly (HEMA-co-
IA)]
Graft copolymerization was performed using 50 ml of poly-
merization recipes containing constant amounts of CTS
(1 g), HEMA (0.5 g), KPS (0.025 g) and varying amounts of
IA viz., 0.1 g (CHI-1), 0.2 g (CHI-2), 0.3 g (CHI-3), 0.5 g
(CHI-5) and 1.0 g (CHI-10). In a typical grafting experiment,
1 g of CTS was dissolved in 50 ml of distilled water containing
0.5 g of IA by continuous stirring at room temperature in a
four necked round bottom ﬂask equipped with mechanical stir-
rer, reﬂux condenser, thermometer and nitrogen gas inlet.
After complete dissolution, the temperature was raised to
70 C, and 0.5 g of inhibitor freed HEMA was added immedi-
ately with the simultaneous addition of 25 mg of KPS initiator
as a solution in 10 ml of distilled water. The reaction mixture
was stirred continuously for another 8 h at 70 C under nitro-
gen. This resulted in a grafted copolymer as a reaction mixture
with a highly swollen viscous solution form. Hence, poly
(2-hydroxylethyl methacrylate) which is insoluble and non-
swellable in aqueous acetic acid may not be formed through
homopolymerization of HEMA. After precipitation of the
copolymer from the grafted reaction mixture using ice cold
acetone, the graft copolymer separated becomes insoluble in
aqueous acetic acid but swellable. Hence, repeated washing
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Figure 1 Chemical structure of drugs and monomers.
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chitosan and the homopolymer poly(itaconic acid). The graft
copolymer obtained was also soxhlet extracted with metha-
nol–water (1:2) to remove unreacted monomers and other sol-
uble impurities if any. The puriﬁed polymer was dried under
vacuum at 60 C for 24 h. The grafting percentage (GP) for
the graft copolymerization was calculated using the equation
GP ¼ ½ðWg W0Þ=W0  100
where, Wg and W0 denote the weights of graft copolymer
obtained and CTS taken for the grafting experiment,
respectively.
A blank experiment was also conducted for grafting on
chitosan without the monomers under the same experimental
conditions of grafting and >99% of the chitosan was recov-
ered after the blank reaction. Hence, degradation of chitosan
during the grafting may not be signiﬁcant and may be
neglected.3. Characterization
3.1. Fourier transform-infrared (FT-IR) spectroscopy
FT-IR spectra of CTS and CTS-graft-poly(HEMA-co- IA)
were recorded on KBr pellet for the spectral range 400–
4000 cm1 using Shimadzu FT-IR-8400S at a resolution of
2 cm1 with number of scans 48.
3.2. Thermogravimetry & derivative thermo gravimetry (TG &
DTG)
TG/DTG studies were performed on TGA Q500 V20.10 Build
36 with a sample size of 1.5–3.5 mg under nitrogen atmosphere
at a heating rate of 10 C/min for the temperature range from
ambient to 800 C.
3.3. Tablet preparation
The dried graft copolymer and CTS were ﬁnely powdered
using a mortar and pestle and sieved through No. 10XXX
mesh (mesh size: 150). In a typical tablet (2.5 mm thickness
and 13 mm diameter) formulation exactly 200 mg of graftcopolymer was loaded with 35 mg of TRM by mixing and
grinding in a mortar and pestle to ensure homogeneity and
then compressed using a KBr press (Techno Search M15) at
5 ton pressure. The prepared tablets were also weighed using
a ﬁve decimal electronic balance (Mettler Toledo AB265-S).
A pure copolymer pellet of the above dimensions was also fab-
ricated similarly without drugs for swelling studies.
3.4. Swelling studies
Swelling studies were performed in both SGF and SIF (PBS)
at 37 C on copolymer pellets (100 mg, 2.55 mm thickness
and 13 mm diameter). The pellet was kept in a stainless-steel
(SS) cylindrical mesh (30 mm diameter; 50 mm height) im-
mersed in 20 ml of SGF or SIF taken in a 25 ml beaker
and allowed to swell. The weights of the swelled copolymers
at predetermined time intervals were calculated after wiping
the mesh containing the swelled polymer with a tissue paper.
Then a graph was drawn between the degree of swelling
(=(WtW0)/W0) and time, where Wt and W0 are the
weights of the polymer after and before swelling,
respectively.
3.5. Differential scanning calorimetry (DSC)
DSC thermograms of FU and TRM drugs and their tablets
were recorded on Perkin Elmer Pyris 6DSC model in nitrogen
atmosphere at a heating rate of 10 C per minute. The samples
(4–5 mg) were subjected to repeated heating and cooling cycles
between room temperature and 175 to remove the previous
thermal history of the sample if any before recording the ﬁnal
thermogram up to 300 C.
3.6. UV–Visible spectrophotometer
UV spectra of the pure drug solution and the drug released
from the tablet in drug dissolution studies were recorded on
Perkin Elmer Lamda 35 UV–VIS spectrophotometer
(UVWINLAB software). The drugs PCM, FU, VNF and
TRM were estimated in drug release studies by measuring their
absorbances at their kmax values of 243 nm (Kwakye and Fell,
2003), 266 nm (Huang et al., 2010), 274 nm (Obaidat and Oba-
idat, 2001) and 271 nm (Shan et al., 2009), respectively.
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Figure 3 Variation of graft copolymer yield (%) with IA
concentration in the feed.
266 K. Subramanian, V. Vijayakumar3.7. In vitro drug dissolution study
In vitro drug dissolution studies were performed in an USP
apparatus Type II (Veego Model VDA-6DR) in SGF and
SIF (Shantha et al., 1995) at 37 C by embarking the com-
pressed tablet inside the rotating (50 RPM) SS basket im-
mersed in a thermostated biological ﬂuid. The tablets
maintain their integrity and shape during swelling for a period
of time >2 h. The amount of drug released was estimated UV-
spectrophotometrically by withdrawing aliquots of sample
from the drug release vessel at different known time intervals
and measuring their absorbance values at 271 nm (Tiwari
et al., 2003; Shan et al., 2009). An average of three identical
experiments was taken to determine the amount of drug re-
leased for a given set of experimental conditions. To maintain
constant volume of the experimental solution a volume equiv-
alent of aliquot sample as incubated fresh ﬂuids was added to
the solution after each withdrawal.
4. Results and discussion
4.1. Mechanism of graft copolymerization on chitosan
The proposed mechanism for the radical graft copolymeriza-
tion of HEMA and IA at the reported grafting site (Lv
et al., 2009) on CTS is shown in Fig. 2. Since for the increased
concentration of HEMA at ﬁxed concentrations of CTS and
IA in the monomer feed, the copolymer formed are brittle
and the tablet fabrication was difﬁcult as it breaks, in the pres-
ent study graft copolymers were synthesized with ﬁxed CTS
and HEMA concentrations with varying concentrations ofO
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Figure 2 Mechanism for radical graIA. The percentages of grafting obtained for varying IA con-
tent in the feed depicted in Fig. 3 indicates that graft copoly-
mer yield increases only marginally with increasing IA
concentration due to lower reactivity ratio of IA compared
to HEMA (Cowie et al., 2000). The disproportionate yield of
the graft copolymer with increasing concentration IA may also
be attributed to the decreased adsorption of IA monomer on
the copolymer with increasing IA concentration as reported
in the copolymerization of HEMA and IA (Cowie et al.,O
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Figure 5 TG (A) and DTG (B) traces for (a) CTS, (b) CTS-
graft-poly (HEMA-co-IA), and (c) CTS–PHEMA–PIA blend.
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age of three grafting yields obtained under identical conditions
for each composition and were in the range 60–80% depending
on the % composition of monomers and chitosan. Since the
graft copolymer is insoluble in most of the common organic
solvents, its molecular weight or inherent viscosity and its
NMR spectra could not be studied in the present study. But
the graft copolymer swells in aqueous acetic acid.
4.2. Characterization
4.2.1. FT-IR spectroscopy
The FT-IR spectra of CTS and its graft copolymer showed
(Fig. 4) a broad absorption band in the range 3000–3500 cm1
attributed to O–H stretching vibrations. The peaks around
2885, 1650, 1589, 1326 and 1080 cm1 in the FT-IR spectrum
of CTS shown in Fig. 4a are due to the stretching vibrations
of aliphatic C–H, Amide I (–NH deformation of –NHCOCH3),
Amide II, Amide III (Miya et al., 1980; Sugama andCook, 2000)
andC–O–C, bonds, respectively. These are characteristics of the
CTS polysaccharide (Radhakumary et al., 2003). Similarly the
peaks observed around 2885, 1558 and 1080 cm1, in the FT-
IR spectrum of the CTS-graft-poly (HEMA-co-IA) (Fig. 4b)
are attributed to the stretching vibrations of aliphatic C–H,
Amide I (C = O stretch of amide group), and C–O–C, respec-
tively. The peak around 1725 cm1 was assigned to the carbonyl
groups of HEMA and IA. This peak together with the broaden-
ing of the –OH stretching peak around 3430 cm1 conﬁrmed the
grafting of these monomers on CTS. Since the carbonyl groups
in PHEMA and PIA absorb very closely around 1725 and
1728 cm1, respectively (Ferreira et al., 2000; Sugama andCook, 2000) in CTS-graft-poly (IA-co-HEMA), these peaks
overlapped and appeared as a single peak (Fig. 4b) due to over-
lapping. Analysis of FT-IR spectra of FU and TRM tablets
(Fig. 4d and f) do not reveal any signiﬁcant polymer–drug inter-
action at molecular level i.e., at <20 nm scale in the solid state.
4.2.2. TG and DTG
TG and DTG thermograms of CTS and CTS-graft-poly
(HEMA-co-IA) recorded in nitrogen atmosphere are displayed
in Fig. 5A and B, respectively. The weight losses around
100 C in CTS and CTS-graft-poly (HEMA-co-IA) are attrib-
uted to loss of moisture and other volatile impurities. The TG/
DTG of graft copolymer displayed three step degradation in
the temperature range 150–600 . The weight loss in the tem-
perature range 250–400 C with maximum weight loss around
289 C (51.34%) is attributed to chitosan back bone degrada-
tion, a complex process including dehydration of the saccha-
ride rings, depolymerization with the formation of water,
CO2 and CH4 (Isiklan et al., 2010). The weight loss around
170 C is more likely attributed to degradation of poly (IA-
co-HEMA) fragment on the CTS back bone with terminal
double bonds. The weight losses observed around 280 and
380 C are due to onset degradations of CTS moiety, and poly
(IA-co-HEMA) residue with saturated terminal ends and CTS
moiety, respectively. A degradation step noticed around
430 C in CTS not seen in the copolymer and the observed
residual weights of 8.1% and 1.6% at 830 C in the TG traces
of CTS and CTS-graft-poly (HEMA-co-IA), respectively, col-
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Figure 6 DSC thermograms for (a) CTS-graft-poly (HEMA-co-
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268 K. Subramanian, V. Vijayakumarlectively reveals that the graft copolymer with a decreased ther-
mal stability degrades faster (Naguib,2002; Isiklan et al., 2010)
compared to CTS. This was also corroborated by the residual
mass of 7.1% at 830 C in the TG traces of the polymer blend
of PIA, PHEMA and CTS (Fig. 5A and B(b)). The degrada-
tion behavior of the blend, CTS and the graft copolymer are
quite different indicating that the TG traces of graft copolymer
displayed is not a physical mixture of CTS and the homopoly-
mers. Different thermal degradation behavior of the graft
copolymer compared to that of the blend also revealed that
the grafting had occurred.
4.2.3. DSC
Typical DSC traces for TRM and FU tablets are displayed in
Fig. 6. It is reported (Argin-Soysal et al., 2009) that the glass
transition temperature (Tg) for CTS was in the range 146–
150 C. Tg of CTS-graft-poly (HEMA-co-IA) was not visible
in the DSC. But the melting endothermic peaks of the drugs
in the matrix are quite visible. The melting points of pure drugs
TRM and FU determined by DSC were 183.25 and 288.77 C
(Singh et al., 2009), respectively. But in the tablets they were
reduced to 177.77 and 280.14 C, respectively. Moreover, the
narrow melting endothermic peaks of the pure drugs become
broadened at the base of the peak with a reduction in the onset0 20 40 60 80 100 120 140 160 180 2000.0
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Figure 7 Degree of swelling of graft copolymer in SGF and SIF
at 37 C.of melting temperature (Fig. 6b and c). This tend to imply the
existence of weak interaction of the drug with the matrix at a
scale >100 nm (Cheung et al., 2000; Manley, 1998).
4.2.4. In vitro swelling studies
The ability of a drug carrier to preserve water is an important
aspect to be investigated for drug delivery applications. To
evaluate this effect, swelling studies were carried out with
CTS and CTS-graft-poly (HEMA-co-IA) in SGF and SIF at
37 C. The degree of swelling in SGF and SIF for CTS-graft-
poly (HEMA-co-IA) polymers (CHI-1, CHI-2, CHI-3, CHI-5
and CHI-10) prepared with increasing concentrations of IA
for ﬁxed concentrations of CTS and HEMA are given in
Fig. 7. The degree of swelling was signiﬁcantly different in
SGF and SIF for a matrix of typical composition. In SIF,
the rate of swelling is more than that in SGF, and it attains
the equilibrium value within 45 min. But in SGF the equilib-
rium swelling rate was attained only after 160 min. The greater
extent of swelling in SIF compared to that in SGF may be
more likely due to enhanced hydrogen bonding between
CTS-graft-poly (HEMA-co-IA) and SIF through the forma-
tion of carboxylate anion (–COO). This may also be due to0 30 60 90 120 150 180 210 240
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Figure 8 Release proﬁles of model drug TRM (A) and of FU,
PCM, TRM and VNF, drugs (B) in SGF and SIF at 37 C, with
graft copolymer carriers.
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localization of water on pepsin by secondary bond forces. At
acidic pH< 2 the majority of the base and acid groups exist
in –NH3
+ and –COO or –NH2 and –COOH forms, and
therefore ionic interaction of –NH3
+ and –COO species
and hydrogen bonding between amine and carboxylic acid lead
to decreased swelling for samples with lower IA content. For
pH values > 7 swelling of the gels may increase again due to
the dissociation of ionic cross linking and the repulsive interac-
tion between negatively charged carboxylic groups (Milosavlj-
evic et al., 2011). But the initial ﬂuid uptake was rapid in both
the ﬂuids due to H-bonding interaction via the carboxylic acid.
This was also supported by the marginal increase in the degree
of swelling in both the ﬂuids with increased concentration of
IA in the copolymer.
4.2.5. In vitro drug dissolution study
The drug tablets were fabricated as discussed earlier (Section
3.3) and placed in the baskets of tablet dissolution test appara-
tus vessels containing biological medium and the amount of
drug released was estimated as discussed earlier and the typical
in vitro drug release proﬁles observed for TRM tablets are dis-
played in Fig. 8A for CTS-graft-poly (HEMA-co-IA) matrices
synthesized with various concentrations of IA in the feed. Both
in SIF and SGF the drug release rate was greater for pure CTS
than that observed for grafted CTS. This was attributed to the
burst release of the drugs due to tablet breaking after immers-
ing in bioﬂuids. For the same drug, the release rate is more in
SIF than in SGF (Fig. 8A). This is more likely attributed to the
greater degree of swelling of the matrix in SIF than in SGF.
But grafting decreased the drug release in both the ﬂuids. This
is more likely attributed to the enhanced drug–polymer inter-
action through H-bonding between –COOH and –OH groups
of CTS-graft-poly (HEMA-co-IA) and –OH group of the drug
as supported by DSC (Fig. 6). With CTS as carrier, 80–85% of
drug was released in SIF for the initial 30 min and this de-
creased to 60% with CTS-graft-poly (IA-co-HEMA matrix.
But in SGF these ﬁgures were 70% and 10%, respectively. It
took roughly 120 min for 60% release of drug in SGF. As in
the case of swelling studies, increased concentration of IA in
the feed increased the drug release rate with the corresponding
copolymer matrix as carrier perhaps due to enhanced swelling
and hence increased diffusion of dissolved drug TRM which is
highly water soluble. Increasing the IA content in polymer will
facilitate enhanced ﬂuid-polymer interaction through H-bond-
ing during swelling. In SIF, the carboxylic groups of the side
chains will be in the ionized state and it opens up the structure.
On the contrary, the CTS could be in the precipitated condi-
tion. These opposing factors will have a net effect on the re-
lease of the incorporated drug from the tablets.
Comparison of the typical release proﬁles of FU, PCM,
TRM and VNF in the copolymer carrier of a typical composi-
tion demonstrated (Fig. 8B) the inﬂuence of chemical structures
of drugs on their release kinetics. The release rates for these
drugs in SGF and SIF were in the order, VNF> TRM>
FU> PCM both in SIF and SGF. The higher release rates
for the drugs VNF and TRM which are bulkier than FU and
PCM may be attributed to their higher solubilities in aqueous
medium. The lowest release rate for PCM is more likely attrib-
uted to the drug–matrix interaction through H-bonding in the
swollen tablet involving phenolic –OH of PCM and its lower
water solubility.4.2.6. Drug release mechanism
To understand and analyze the in vitro drug release proﬁle and
mechanism from amatrix tablet the Korsmeyer–Peppas’s equa-
tion (Korsmeyer et al., 1986; Ritger and Peppas, 1987) viz.,
Mt=M1 ¼ ktn
where Mt/M1 is the fractional release of drug at time ‘t’ or
fractional uptake of ﬂuid in swelling in the absence of drug (Mt
andM1, amounts of drugs released or ﬂuid absorbed at time ‘t’
and at equilibrium, respectively) was used. According to Pep-
pas the above equation could adequately describe the release
of solutes from slabs, spheres, cylinders and disks, regardless
of the release mechanism. The slope of the linear plot logMt/
M1 versus log t, for drug release < 50% gives the power law
exponent (n) value. The equation is physically realistic for
n= 0.5 (pure diffusion-Fickian controlled drug release) and
n= 1 (swelling-controlled drug release or Case II transport:
non-Fickian). For other values of ‘n’ anomalous transport
kinetics, i.e. a combined mechanism of pure diffusion and Case
II transport will be operating. The observed ‘n’ values for typ-
ical release proﬁles of FU, TRM, PCM and VNF were <0.5,
>0.5 and> 1.0. These ranges of ‘n’ values indicate a combined
mechanism of pure diffusion and non-Fickian (Case II trans-
port) for the drug release with the grafted chitosan matrix both
in SGF and SIF. This tend to imply that the driving force for
the ﬂuid penetration and drug release is a combination of con-
centration gradient(Fickian) and polymer relaxation (non-Fic-
kian) as a result of thermodynamic interaction of the solvent
with the polymer. The same drug release mechanism was impli-
cated with virgin CTS as a carrier also. This mechanism may
also be partly due to the weak physical interaction of the poly-
mer matrix with drug at scales > 100 nm as indicated by the
DSC studies on the tablet and the drug.
5. Conclusions
CTS-graft-poly (HEMA-co-IA) hitherto unreported has been
synthesized and characterized for using it as a carrier for oral
drug delivery using TRM as a model drug. Grafting decreased
the thermal stability of CTS. The drug release rate was greater
in SIF than in SGF due to enhanced matrix swelling in SIF,
and lower with CTS-graft-poly (HEMA-co-IA) carrier com-
pared to CTS. In SGF the initial drug release rate was sluggish
but started increasing rapidly after 40 min due to increased
segmental mobility. Increasing the concentration of IA in the
monomer feed enhanced the drug release rate with the corre-
sponding grafted chitosan as carriers due to enhanced poly-
mer–bioﬂuid interaction. For a graft copolymer of speciﬁc
composition the release rates of VNF, TRM, FU and PCM
follows the order VNF> TRM> FU> PCM both in SIF
and SGF implying the inﬂuence of chemical structures of drugs
on their release rate. The higher release rates for VNF and
TRM may be attributed to their higher solubilities in SBF.
The lowest release rate for PCM is more likely attributed to
the drug–matrix interaction through H-bonding and its lower
water solubility. The observed values (0.5–2.2) of power law
exponents indicated a mixed pure diffusion and non-Fickian
mechanisms for drug release in simulated biological ﬂuids.
The above features suggest that the graft copolymer can be
used as a promising matrix candidate for oral drug delivery
system by ﬁne tuning its composition and pH of the simulated
biological ﬂuids.
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